100 related articles for article (PubMed ID: 11572162)
1. Current status of opportunistic infections in patients with HIV infection in the era of highly active antiretroviral therapy.
Masur H; Kaplan J
Curr Clin Top Infect Dis; 2001; 21():64-82. PubMed ID: 11572162
[No Abstract] [Full Text] [Related]
2. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
[TBL] [Abstract][Full Text] [Related]
3. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
4. Upper gastrointestinal endoscopic findings in the era of highly active antiretroviral therapy.
Nkuize M; De Wit S; Muls V; Arvanitakis M; Buset M
HIV Med; 2010 Jul; 11(6):412-7. PubMed ID: 20146733
[TBL] [Abstract][Full Text] [Related]
5. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
6. Opportunistic infections in the era of highly active antiretroviral therapy.
Ferri RS
Lippincotts Prim Care Pract; 2000; 4(1):20-8. PubMed ID: 11022517
[No Abstract] [Full Text] [Related]
7. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
[TBL] [Abstract][Full Text] [Related]
8. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
[TBL] [Abstract][Full Text] [Related]
9. The changing face of mycoses in patients with HIV/AIDS.
Haddad NE; Powderly WG
AIDS Read; 2001 Jul; 11(7):365-8, 375-8. PubMed ID: 11494709
[TBL] [Abstract][Full Text] [Related]
10. Sharp drop in the prevalence of human cytomegalovirus leuko-DNAemia in HIV-infected patients following highly active antiretroviral therapy.
Gerna G; d'Arminio Monforte A; Zavattoni M; Sarasini A; Testa L; Revello MG; Moroni M
AIDS; 1998 Jan; 12(1):118-20. PubMed ID: 9456267
[No Abstract] [Full Text] [Related]
11. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
[TBL] [Abstract][Full Text] [Related]
12. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy.
Werneck-Silva AL; Prado IB
J Gastroenterol Hepatol; 2009 Jan; 24(1):135-9. PubMed ID: 19054257
[TBL] [Abstract][Full Text] [Related]
13. Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005.
Buchacz K; Baker RK; Moorman AC; Richardson JT; Wood KC; Holmberg SD; Brooks JT;
AIDS; 2008 Jul; 22(11):1345-54. PubMed ID: 18580614
[TBL] [Abstract][Full Text] [Related]
14. How infrequent are opportunistic diseases and immune reconstitution syndromes among HIV-infected individuals who have favorable CD4+ cell count responses to antiretroviral therapy?
Phillips P
Clin Infect Dis; 2005 May; 40(9):1379-80; author reply 1380-1. PubMed ID: 15825049
[No Abstract] [Full Text] [Related]
15. Improvement of symptomatic human immunodeficiency virus-related lymphoid interstitial pneumonia in patients receiving highly active antiretroviral therapy.
Dufour V; Wislez M; Bergot E; Mayaud C; Cadranel J
Clin Infect Dis; 2003 May; 36(10):e127-30. PubMed ID: 12746792
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus disease in HIV infection: twenty years of a regional population's experience.
Kim S; Snider JJ; Gill MJ
Clin Infect Dis; 2006 Jun; 42(12):1808-9. PubMed ID: 16705594
[No Abstract] [Full Text] [Related]
17. Current status of HIV infection: a review for non-HIV-treating physicians.
Knoll B; Lassmann B; Temesgen Z
Int J Dermatol; 2007 Dec; 46(12):1219-28. PubMed ID: 18173512
[TBL] [Abstract][Full Text] [Related]
18. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
19. Seven years of HAART impact on ophthalmic management of HIV-infected patients.
Kahraman G; Krepler K; Franz C; Ries E; Maar N; Wedrich A; Rieger A; Dejaco-Ruhswurm I
Ocul Immunol Inflamm; 2005; 13(2-3):213-8. PubMed ID: 16019681
[TBL] [Abstract][Full Text] [Related]
20. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study).
Vellozzi C; Brooks JT; Bush TJ; Conley LJ; Henry K; Carpenter CC; Overton ET; Hammer J; Wood K; Holmberg SD;
Am J Epidemiol; 2009 Mar; 169(5):642-52. PubMed ID: 19074775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
